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Abstract
Objective: To elucidate the presence and potential involvement of brain inflammation and cell
death in neurological morbidity and intractable seizures in childhood epilepsy, we quantified cell
death, astrocyte proliferation, microglial activation and cytokine release in brain tissue from
patients who underwent epilepsy surgery.
Methods: Cortical tissue was collected from thirteen patients with intractable epilepsy due to
focal cortical dysplasia (6), encephalomalacia (5), Rasmussen's encephalitis (1) or mesial temporal
lobe epilepsy (1). Sections were processed for immunohistochemistry using markers for neuron,
astrocyte, microglia or cellular injury. Cytokine assay was performed on frozen cortices. Controls
were autopsy brains from eight patients without history of neurological diseases.
Results: Marked activation of microglia and astrocytes and diffuse cell death were observed in
epileptogenic tissue. Numerous fibrillary astrocytes and their processes covered the entire cortex
and converged on to blood vessels, neurons and microglia. An overwhelming number of neurons
and astrocytes showed DNA fragmentation and its magnitude significantly correlated with seizure
frequency. Majority of our patients with abundant cell death in the cortex have mental retardation.
IL-1beta, IL-8, IL-12p70 and MIP-1beta were significantly increased in the epileptogenic cortex; IL-
6 and MCP-1 were significantly higher in patients with family history of epilepsy.
Conclusions: Our results suggest that active neuroinflammation and marked cellular injury occur
in pediatric epilepsy and may play a common pathogenic role or consequences in childhood epilepsy
of diverse etiologies. Our findings support the concept that immunomodulation targeting activated
microglia and astrocytes may be a novel therapeutic strategy to reduce neurological morbidity and
prevent intractable epilepsy.
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Background
The deleterious contribution of inflammation has been
well established for a growing number of neurological dis-
orders such as cerebral ischemia, traumatic brain injury,
multiple sclerosis, and HIV encephalitis [1]. Involvement
of inflammation in the pathogenesis of epilepsy and sei-
zure-induced brain damage, however, has only recently
been explored [2,3]. Active inflammation has been
detected not only in prototypical inflammatory epilepsies
such as Rasmussen's encephalitis or limbic encephalitis,
but also in patients with pharmacoresistant epilepsy of
diverse causes [2-7]. Pro-inflammatory cytokines, NF-κB,
interleukin (IL)-1β and its signaling receptor IL-1R1 are
highly expressed by neurons and glia in temporal lobe
epilepsy [3,4], focal cortical dysplasia [5], glioneuronal
tumor [6], and in tuberous sclerosis complex [7].
Increased levels of cytokines such as IL-6 [8], IL-1β [9] and
IL-1-receptor antagonist [10] have also been detected in
plasma and cerebrospinal fluid from patients with recent
seizures without evidence of infection. Whether cytokines
contribute directly to pathogenesis of seizures and chronic
epilepsy, or the high levels of cytokines merely reflect acti-
vation following seizures, however, cannot be determined
from these clinical observations. The causative role of
neuroinflammation in the development of chronic epi-
lepsy remains unclear.
In many animal models of epilepsy, acute seizures cause
glial activation and increased cytokine production [11-
13]. Experimentally induced seizures trigger a rapid
inflammatory response in brain areas recruited in the
onset and propagation of epileptic activity [14]. Members
of the Toll-like receptor (TLR) family are significantly up-
regulated by seizures in microglia, and their engagement
leads to transcriptional activation of cytokines, chemok-
ines, MHC class I and II and costimulatory molecules
[11]. The activated glia and elevated cytokines, in turn,
have been demonstrated to contribute to seizure-related
hippocampal pathology, such as neuronal death, neuro-
nal birth, reactive gliosis and mossy fiber sprouting [15].
IL-1β increases glutamatergic neurotransmission and low-
ers the peak magnitude of GABA-mediated currents [16],
contributes to generation of fever-induced seizures [17]
and prolongs the electroencephalographic seizure dura-
tion [18]. Available experimental data thus suggest that
seizure-induced glial activation and up-regulation of pro-
inflammatory cytokines can lead to neuronal excitability
and neuronal injury either directly by interacting with
glutamatergic neurotransmission, or indirectly by activat-
ing gene transcription.
Microarray analyses in our laboratory have shown that
genes coding for classical inflammatory mediators - com-
plement pathway, cytokines and glial markers - are acutely
increased in both immature and mature rat hippocampus
after kainic acid (KA)-induced seizures [19]. Inflamma-
tion-related genes are the functional group that are most
significantly up-regulated acutely, and they remain ele-
vated 10 days after seizures in mature, but not in imma-
ture, hippocampus. Persistent inflammation occurring
only in older animals (that show seizure-induced cell
death and subsequently develop spontaneous recurrent
seizures) implies a causative role of chronic active inflam-
mation in epileptogenesis and seizure-induced cell death.
These age-dependent increases are reflected in tissue
microglial activation [20,21]. In order to determine
whether active inflammation and neuronal degeneration
occur in pediatric epilepsy, we processed brain tissue from
patients with intractable childhood epilepsy. We quanti-
fied DNA fragmentation for cell injury and looked for the
evidence of inflammation by astrocyte and microglia
staining and by cytokine assay.
Methods
Patient information
Thirteen patients with chronic intractable epilepsy who
underwent epilepsy surgery from January 2006 to June
2007 were included in order of operation (Table 1). Nor-
mal-appearing control cortex was obtained at autopsy
from eight patients without seizures or other neurological
diseases. All autopsies were performed within 12 hours
after death. Extensive pre-surgical evaluation included
video-EEG-monitoring, MRI, and electrocorticography, as
well as ictal and interictal SPECT and FDG-PET-imaging as
needed. None of our patients had a grid placement or
other invasive monitoring prior to functional hemi-
spherectomy or lobectomy. This study was approved by
Institutional Review Board at the Children's Memorial
Research Center and at the Northwestern Memorial Hos-
pital.
Brain tissue processing
Fixed or frozen brain tissue was obtained at the time of
resection in the operating room. The cortical gray matter
(cortex) was rapidly dissected and cut into approximately
5 mm3 pieces and immediately frozen in cooled isopen-
tane over dry ice, and stored at -80°C. A block of resected
tissue including both cortex and subcortical white matter
was emersion fixed in 4% paraformaldehyde solution in
100 mM PBS, pH 7.4. After fixation, tissue was cryopro-
tected in 30% sucrose and 50 μm-thick serial sections
were cut and collected. A total of 22 regions from 11
patients (Table 2) were processed for immunohistochem-
istry as described below. Adjacent sections were processed
for in situ end labeling (ISEL) nick translation to detect
DNA fragmentation as a marker for cell injury and Fluoro-
Jade B staining to detect degenerating cells.
Immunohistochemistry and in situ end labeling nick 
translation histochemistry (ISEL)
Antibodies to glial fibrillary acidic protein (GFAP, DAKO,
Glostrup, Denmark) for astrocytes, neuronal nuclear pro-Journal of Neuroinflammation 2009, 6:38 http://www.jneuroinflammation.com/content/6/1/38
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tein (NeuN, Chemicon, Temecula, CA) for neurons, and
CD68 (KP1, DAKO) for microglia and macrophages were
used. For immunohistochemistry, free floating sections
were processed using the avidin-biotin peroxidase
method with 3, 3-diaminobenzidine. To examine the spa-
tial relationship between neurons, astrocytes and micro-
glia, double or triple immunofluorescence was
performed. Briefly, the sections were mounted on pre-
mium microscope slides (Fisher Scientific, Pittsburgh, PA)
and were incubated with anti-GFAP or anti-CD68 at 4°C
overnight followed by biotinylated secondary antibodies.
The sections were then treated with HRP-conjugated
streptavidin followed by tyramide-Alexor Flour (Molecu-
lar Probe, Eugene, OR) for 1 hour at room temperature.
After washing, the sections were treated with anti-NeuN
followed by fluorescein anti-mouse antibody. To quench
endogeneous autofluorescence, tissue sections were
treated with 1% Sudan black in 70% ethanol for 5 min
and differentiated with 70% ethanol. Specimens were
examined in a Zeiss LSM 5.0 confocal microscope (Zeiss,
Thornwood, NY). For detection and quantification of
DNA fragmentation, sections were processed for ISEL as
previously described [22]. To determine the cell types
showing DNA fragmentation, we performed triple
Table 1: Clinical findings in epilepsy patients.
Age (yr) at Seizure Post-op F/u
No Sex Op Onset Dur (yr) Freq/
month
FHx Feb sz MR ADHD HP Dur 
(yr)
Sz 
outcome
Epileptogenic 
focus
Diagnosis
1 F 2.9 2.5 0.4 30-450 -- -- † -- R 3.0 sz-free L hemisphere cortical dysplasia
2 M 2.4 1.5 0.9 30-120 † -- † -- -- 2.0 sz-free L.inf. temporal cortical dysplasia
3 M 4.4 0.2 4.2 60 † -- † -- L 1.8 75% ↓ R frontal, 
central
mid-temporal
cortical dysplasia
4 M 3 0.1 2.9 1-4 -- -- † -- L 1.6 sz-free R post 
temporo-
occipital
cortical dysplasia
5 M 7.5 4.8 2.7 150-300 -- -- † -- R 2.7 sz-free L hemisphere encephalomalasia
stroke
6 F 19.5 3 16.5 4-8 † -- † -- L 2.5 sz-free R parieto-
temporo-
occipital
encephalomalasia
stroke
7 F 9.7 4 5.7 90-120 N/A -- † † L 2.3 sz-free R hemisphere encephalomalasia
traumatic injury
8 F 13.2 8 5.2 120 † -- -- -- -- 2.1 sz-free R frontal encephalomalasia
tumor resection
9 M 28 13 15 30-60 -- -- † -- -- 2.6 sz-free R temporal encephalomalasia
traumatic injury
10 F 9 7 2 1-4 -- † -- † -- 1.6 sz-free L ant-middle
temporal
hippocampal 
sclerosis
11 F 9.2 5.8 3.4 500 -- † † † L 2.1 sz-free R hemisphere Rasmussen's 
encephalitis
12 M 17 9 8 30-60 -- -- -- † -- 2.9 sz-free L frontal cortical dysplasia
13 F 18 12 6 4-16 † -- † -- L 1.6 sz-free R frontal cortical dysplasia
Op = operation; yr = year; Dur = duration; freq = frequency; FHx = (+) family history of epilepsy; Feb sz = febrile seizure; MR = mental retardation; 
ADHD = attention deficit hyperactivity disorder; HP = hemiparesis; F/U = follow-up; F = female; M = male; Sz = seizure; L = left; R = right; inf = 
inferior; post = posterior; N/A = not applicable.Journal of Neuroinflammation 2009, 6:38 http://www.jneuroinflammation.com/content/6/1/38
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Table 2: Brain tissue information
Tissue Data used for analysis
Patient No. Age Diagnosis Brain 
Region
Fixed Frozen IHC Cytokine Correlation
1 2.9 cortical 
dysplasia
frontal † † †
temporal † † † †
2 2.4 cortical 
dysplasia
anterior 
temporal
†† † †
inferior 
temporal
†† † †
3 4.4 cortical 
dysplasia
temporal † † † † †
4 3 cortical 
dysplasia
temporal † † †
parietal † †
occipital † † † † †
5 7.5 encephalomalacia temporal † † † † †
occipital † †
6 19.5 encephalomalacia anterior 
temporal
††
lateral 
temporal
†† † † †
temporal † † †
occipital † †
7 9.7 encephalomalacia frontal † † †
temporal † † † †
8 9.2 encephalomalacia frontal † † † † †
9 28 encephalomalacia lateral 
temporal
†† † † †
10 9 hippocampal 
sclerosis
temporal † † † † †
11 9.2 Rasmussen's
encephalitis
frontal † † †
superior 
temporal
†† † †
perisylvian/insular † †
12 17 cortical 
dysplasia
temporal † † †
13 18 cortical 
dysplasia
temporal † † †
Control No.
11 5 a s t h m a t e m p o r a l † † †
2 0.9 pneumonia frontal † † †
temporal † † †
parietal † † †Journal of Neuroinflammation 2009, 6:38 http://www.jneuroinflammation.com/content/6/1/38
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immunofluorescent staining for neuron, microglia or
astrocytes using TSA-amplification with ISEL. Adjacent
sections were processed for Fluoro-Jade B histochemistry
as previously described [23] to confirm the detection of
degenerating neurons by ISEL staining.
Quantitative analysis of immunoreactive profiles
At least 5 representative fields from 5-7 tissue sections
obtained from different cortical regions of each patient
were evaluated (Table 2). The cortex and white matter
were analyzed and quantified separately. Images of at
least 500 cells were captured digitally at 20x magnifica-
tion, converted to gray scale, and areas of specific immu-
noreactive cells were highlighted at a threshold held
constant for all specimens and quantified using an image
analysis system, MetaMorph (v. 6.1, Universal Imaging
Corp., Downingtown, PA) as previously described [24].
An average percent area above the threshold was calcu-
lated per brain region and comparison was made between
individual patients or between epilepsy sub-groups of
common etiology and controls. For quantification of cel-
lular subtypes showing DNA fragmentation, three sec-
tions from three patients proven to have high DNA
fragmentation were selected and five images each from
cortical area were captured digitally at 25x magnification
in a confocal microscope. Percent of cells double-labeled
with NeuN, GFAP or CD68 and fragmented DNA over
total number of ISEL-positive cells was calculated.
Measurement of cytokines and chemokines
Frozen cortices from all patients (n = 13) and available
controls (n = 2) (Table 2) were homogenized with PM
buffer from a total protein extraction kit (Chemicon,
Temecula, CA), then centrifuged at 4°C and stored at -
80°C. Total protein concentration was calculated using
the BCA assay kit (Pierce, Rockford, IL). Levels of proin-
flammatory cytokines including interferon (IFN)-γ, IL-1β,
IL-2, IL-6, IL-8, IL-12p70, TNF-α, granulocyte-macro-
phage colony stimulating factor (GM-CSF), anti-inflam-
matory cytokine IL-10, and chemokines including
eotaxin, eotaxin-3, IFN-inducible protein 10 (IP-10),
MCP-1, MCP-4, macrophage derived chemokine (MDC),
macrophage inflammatory protein 1β (MIP-1β), and thy-
mus and activation-regulated chemokine (TARC) were
measured using ELISA-based commercially available kits
(Meso-Scale Discovery, MSD, Gaithersburg, MD). Sam-
ples were analyzed in duplicates and compared with con-
trols. Plates were analyzed using the SECTOR Imager 2400
(MSD).
Statistical Analysis
A one-way analysis of variance (ANOVA) was used to
compare immunoreactive profiles for astrocytes, micro-
glia and DNA fragmentation between controls and
patients. For multiple comparison groups, Tukey's correc-
tion was applied (GraphPad Prism v. 4.0, GraphPad Soft-
ware Inc., San Diego, CA). Nonparametric Spearman's
rank correlation coefficient was calculated to find signifi-
cant correlations between glia activation, DNA fragmenta-
tion, different clinical variables and cytokine levels.
Student t-test was used to compare age of onset and dura-
tion of seizures between cortical dysplasia and encephalo-
malasia. Nonparametric Mann-Whitney test was used to
compare cytokine and chemokine levels between controls
and patients. We included all available quantification
data for correlation, while select representation from each
patient was used for group comparison between controls
and patients (see Data used for analysis, Table 2). Values
3 0.5 sepsis frontal † † †
temporal † † †
4 64 hypertension,
diabetes 
mellitus
frontal † † † † †
occipital † † † †
5 79 sepsis frontal † † † † †
occipital † † † †
6 15.1 Vehicle 
accident 
(chest)
Frontal, 
temporal
†† † †
7 8 Cardiac 
arrhythmia
Frontal, 
temporal
†† † †
8 31.8 Alcohol 
intoxification
Frontal, 
temporal
†† † †
Op = operation; yr = year; Dur = duration; freq = frequency; FHx = (+) family history of epilepsy; Feb sz = febrile seizure; MR = mental retardation; 
ADHD = attention deficit hyperactivity disorder; HP = hemiparesis; F/U = follow-up; F = female; M = male; Sz = seizure; L = left; R = right; inf = 
inferior; post = posterior; N/A = not applicable.
Table 2: Brain tissue information (Continued)Journal of Neuroinflammation 2009, 6:38 http://www.jneuroinflammation.com/content/6/1/38
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are expressed as mean ± SEM and significance was defined
as p < 0.05 for all tests.
Results
Patient characteristics and pathology
Table 1 summarizes the patient's clinical data. The two
main causes of chronic intractable childhood onset epi-
lepsy were focal cortical dysplasia (FCD, 6 cases) and
encephalomalacia (EM, 5 cases) due to intrauterine mid-
dle cerebral artery (MCA) stroke (2 cases), traumatic brain
injury (2 cases) and previous resection of giant cell astro-
cytoma (1 case). There was one case each of Rasmussen's
encephalitis (RE) and mesial temporal lobe epilepsy with
hippocampal sclerosis (TLE). While both patients with RE
and TLE had history of prolonged febrile seizures in early
childhood, none of our patients with cortical dysplasia or
encephalomalacia had experienced febrile seizures. There
was a tendency toward younger age of seizure onset (4.2
years ± 2.1 vs. 6.6 years ± 1.8, p < 0.43) and shorter dura-
tion of seizures (3.7 years ± 1.2 vs. 9.0 years ± 2.8, p <
0.098) for patients with cortical dysplasia compared to
encephalomalasia group. Interestingly, microglia activa-
tion was detected equally in gray and subcortical white
matter in patients with cortical dysplasia while microglia
were significantly increased only in subcortical white mat-
ter in 3/4 patients with encephalomalasia (Fig. 1). Within
the cortical dysplasia group, patients with family history
of epilepsy (no. 2 & 3) were noted to show significant acti-
vation of microglia while patient 1 and 4 with no family
history of epilepsy failed to show significant microglia
activation. Patient 1 and 2 with cortical dysplasia were
noted to have high amount of fragment DNA in cortical
gray matter that is comparable to the patient with Rasmus-
sen's encephalitis. They experienced relatively short dura-
tion of epilepsy (0.7 years), but had intense seizures with
an average of 280 seizures per month. Encephalomalacia
resulted from various etiologies: prenatal middle cerebral
artery infarction (5 & 6), nonaccidental trauma (7), tumor
removal (8) and a fall with massive intracranial hemor-
rhage (9). There was significant DNA fragmentation in all
but one patient (9). The only feature that distinguished
this patient from other EM patients was relatively late
onset of epilepsy (13 years vs. 5). Our 9 year old TLE
patient with hippocampal sclerosis had no risk factors
other than febrile status epilepticus and showed no DNA
fragmentation as previously noted in adult TLE patients
[25]. All but three of our patients had mental retardation.
At the most recent postoperative follow-up [1.6-to-3 year
(mean 2.2 year)], twelve patients (92%) were seizure-free
and one patient had 75% reduction in seizure frequency.
Diffuse microglial activation in chronic intractable 
childhood epilepsy
Significant microglial activation was observed in the
resected cortices of our patients (p  < 0.0001) (Fig. 1).
Microglial activation involving both cortex and white
matter was found not only in a patient with Rasmussen's
encephalitis as expected, but also in two patients with
focal cortical dysplasia and one with encephalomalacia
(patient 7) (Fig. 1A). Notably, microglia were diffusely
and uniformly distributed in these patients (Fig. 1D, 1E,
1H and 1I), while they formed localized nodules in the
case with Rasmussen's encephalitis (Fig. 1F and 1J). Sig-
nificant microglial activation was limited to the white
matter in 4 patients (4/11, 36%, p < 0.001) (Fig. 1A). In
control brains, only rare CD68 immunoreactive microglia
were detected and scattered around the perivascular
spaces (Fig. 1C and 1G).
Panlaminar reactive astrocytosis in the brains of pediatric 
epilepsy surgery patients
All of our patients had diffuse astocyte proliferation that
obscured the borders of the gray-white matter junction (p
< 0.0001) (Fig. 2). Entire cortical layers and white matter
were covered by diffuse astrocytic infiltration and were
darkened by profuse astrocytic processes, thus rendering
the whole brain section dark brown. A thin layer of sub-
pial gliosis was expanded 2- to 5-fold in our patients, thus
further obliterating the normal cortical architecture (Fig.
2).
Close association among neurons, microglia and astrocytes
Neurons, microglia and astrocytes were often found next
to each other and displayed overlapping cell bodies and
processes suggesting intimate interaction between these
three cell types (Fig. 3). Microglia and astrocytes were
often increased in the same region in the cortex and
showed trends toward correlated localization (p = 0.054)
(Fig. 3I). Numerous reactive astrocytes were found in the
cortex juxtaposed to neurons, microglia, and blood ves-
sels (Fig. 3B, 3C, 3G and 3H; Fig. 2K). DNA fragmentation
was inversely correlated with microglial activation (r = -
0.37, p < 0.02) (Fig. 3J).
Diffuse DNA fragmentation and degenerating neurons in 
chronic intractable childhood epilepsy
Acute cell injury demonstrated by dense staining of DNA
fragmentation and Fluro-Jade B-positive degenerating
neurons was significantly increased in epileptic lesions (p
< 0.0001) (Fig. 4). DNA fragmentation encompassed all
cortical layers, as well as the white matter (Fig. 4E, 4F, 4G,
4P and 4Q) and was correlated with Fluoro-Jade B-posi-
tive degenerating neurons (Fig. 4M-4O). Control brains
showed no evidence of DNA fragmentation or neuronal
degeneration (Fig. 4D and 4L). Neurons (60%) comprised
the majority of cell type with DNA fragmentation fol-
lowed by astrocytes (26%), and other cells including oli-
godendrocytes (14%) (Fig. 4H-4K and 4P-4S).
Fragmented DNA was rarely found in endothelial cell
layer of blood vessels or microglia, which appeared rela-Journal of Neuroinflammation 2009, 6:38 http://www.jneuroinflammation.com/content/6/1/38
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tively spared from injury (red arrows, Fig. 4I). Thickened
microglial processes wrapped around the cell bodies as if
engulfing fragmented DNA of disintegrating neurons and
astrocytes (Fig. 4R4). The amount of DNA fragmentation
both in the cortex and white matter was significantly cor-
related with the seizure frequency prior to surgery (p <
0.003) (Fig. 4C). The other clinical variables, such as age
of onset of seizure, duration of seizures, presence of
febrile seizure, family history of epilepsy, mental retarda-
tion or hemiparesis, however, did not show a significant
correlation with DNA fragmentation.
Increased levels of proinflammatory cytokines and 
chemokines in the resected cortices from pediatric 
epilepsy patients
IL-1β, IL-8, IL-12p70 and MIP-1β were significantly
increased in the cortex of our patients (Fig. 5) (p < 0.05).
IL-6, MCP-1, IP-10, and MDC were increased in some, but
not all patients. A few patients showed markedly elevated
IL-1β or IL-6 levels, even higher than levels in the patient
with Rasmussen's encephalitis (black circle in Fig. 5).
There was a significant correlation between a family his-
tory of epilepsy and specific cytokine levels: IL-6 and
MCP-1 were higher in patients with family history of epi-
lepsy than sporadic cases (Fig. 5G and 5H) (p < 0.05).
Notably, IL-6 and MCP-1 were elevated significantly in
the patient with Rasmussen's encephalitis (black circle in
Fig. 5G and 5H) uniquely among the sporadic cases.
Discussion
The main findings of present study are the demonstration
of abundant cell injury, marked glial activation and neu-
roinflammation in the surgically resected cortical tissue
from patients with intractable epilepsy. Dense, extensive,
and wide-spread fragmented DNA was found both in the
cortex and in white matter of the resected brain tissue.
Quantification of CD68 immunoreactive microglia in the cortex (cortical GM) and white matter (subcortical WM) Figure 1
Quantification of CD68 immunoreactive microglia in the cortex (cortical GM) and white matter (subcortical 
WM). (A) CD68-immunoreactivity in individual patients (patients No. 1 to 11) and controls (n = 5). Significant microglial acti-
vation was noted in 8/11 patients (73%, p < 0.05). (B) Fold changes in the CD68-immunoreactivity in epilepsy subgroups com-
pared to controls. Note the magnitude of microglia activation (nearly 20-fold increase in the cortex) in FCD and EM is 
comparable to RE. (C-J) CD68-immunoreactiviy in the cortex (upper panel) and white matter (lower panel). Controls show 
very rare microglia (C, G). Focal cortical dysplasia (D, H) and encephalomalacia (E, I) show uniform increase in microglia 
while Rasmussen's encephalitis (F, J) show microglial aggregates. Bar = 20 μm. *p < 0.05, ** p < 0.01, *** p < 0.001, one-way 
ANOVA.Journal of Neuroinflammation 2009, 6:38 http://www.jneuroinflammation.com/content/6/1/38
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Quantification of GFAP immunoreactive astrocytes in the cortex and white matter Figure 2
Quantification of GFAP immunoreactive astrocytes in the cortex and white matter. (A) GFAP-immunoreactivity 
in individual patients (patients No. 1 to 11) and controls (n = 5). (B) Fold changes in the GFAP-immunoreactivity in epilepsy 
subgroups compared to controls. (C, D & E) Control: cortex, gray-white junction and white matter. (F, G & H) Epilepsy case: 
cortex, gray-white junction and white matter. Notice loss of clear gray-white demarcation in epilepsy case (G) compared to 
control (D). (I-K) High magnification of an epilepsy case. (I) Expanded subpial gliosis. (J) Cortical astrocytes with numerous 
thin and elongated processes, morphologically resembling fibrillary astrocytes. (K) Astrocytic end feet adhering to the wall of 
blood vessel. Bars: C-H = 100 μm; I-K = 20 μm. * p < 0.05, ** p < 0.01, *** p < 0.001 by one-way ANOVA.Journal of Neuroinflammation 2009, 6:38 http://www.jneuroinflammation.com/content/6/1/38
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Panlaminar astrocytosis, diffuse microglial activation and
release of proinflammatory cytokines and chemokines
consistent with chronic and sustained neuroinflamma-
tory responses were present in the epileptogenic lesions. It
appears that intractable epilepsy in childhood, regardless
of the cause, age, history of febrile seizure or family his-
tory of epilepsy, is marked by ongoing active cell injury
and glial activation. What used to be considered a hall-
mark of Rasmussen's encephalitis - neuronal injury and
microglial activation - is also noted in our cases of focal
cortical dysplasia and encephalomalacia, two common
causes of intractable childhood epilepsy.
Microglial activation and proliferation have been demon-
strated in sclerotic hippocampal tissue [26], within the
dysplastric cortex of focal cortical dysplasia [5], and
within and around the tumor bed in highly epileptogenic
gangliogliomas and dysembryoplastic neuroepithelial
tumors [6]. The density of activated microglia correlated
both with the duration of epilepsy and with the seizure
frequency [5,6].
Triple immunofluorescence confocal images of neurons (green), microglia (blue) and astrocytes (red) Figure 3
Triple immunofluorescence confocal images of neurons (green), microglia (blue) and astrocytes (red). Low 
magnification view of cortex (A) and white matter (B). (C--H) Higher magnification view showing close contact between 
microglia and astrocytes (C, D), neurons and microglia (E, F) and neurons and astrocytes (G, H). Activated microglia tend to 
co-localize with astrocytes (p = 0.054) (I). Activated microglia is inversely correlated with DNA fragmentation (p < 0.02, r = -
0.38) (J). Bar = 20 μ m.Journal of Neuroinflammation 2009, 6:38 http://www.jneuroinflammation.com/content/6/1/38
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Quantification and Triple immunofluorescence confocal images of DNA fragmentation in the cortex and white matter Figure 4
Quantification and Triple immunofluorescence confocal images of DNA fragmentation in the cortex and white 
matter. (A) DNA fragmentation in individual patients (patients No. 1 to 11) and controls (n = 5). Notice that the majority of 
our patients [6/10, except RE (No. 11)] showed diffuse cell injury that is comparable to the patient with Rasmussen's encepha-
litis (No. 11). (B) Fold changes in DNA fragmentation in epilepsy subgroups over controls. (C) The magnitude of DNA frag-
mentation is significantly correlated with seizure frequency prior to surgery (p = 0.002). (D) Low magnification view of a 
control shows no evidence of DNA fragmentation. (E-G) Epilepsy case. Low and high magnification of cortex (F) and white 
matter (G) show increased DNA fragmentations. (H-K) Higher magnification view of DNA fragmentation in neurons (black 
arrows), oligodendrocytes (green arrows) and astrocytes (blue arrows) in cortex (H, I and J) and white matter (K). Microglia 
were spared (red arrows). The identification of different cell types was made based on nuclear morphology. Neurons have 
large vesicular nuclei and oligodendrocytes have round uniform nuclei while astrocytes have bipolar elongated nuclei with 
irregular borders. Small rod-shaped nuclei of microglia show only faint staining. (L-O) Fluoro-Jade B staining in control (L) and 
epilepsy cases (M-O). Positive staining in the cortex (M, N) and white matter (O) of epilepsy cases and not in controls are con-
sistent with cell injury noted by in situ end labeling of DNA fragmentation. (P-S) Triple immunofluorescence confocal images of 
cellular subtypes showing DNA fragmentation in the cortex (P, R) and white matter (Q, S) of focal cortical dysplasia patient; 
Low magnification (P) shows that neurons comprise the majority of cells with DNA fragmentation. Double labeling of neuron 
and DNA fragmentation is magnified and microglia closely associated with these neurons are also labeled with fragmented 
DNA (Fig. R4). DNA fragmentation (blue); microglia (red); neuron (green). (P, R) White matter. DNA fragmentation (blue); 
astrocyte (red); neuron (green). Low (Q) and high magnification (S) show double labeling of astrocytes with DNA fragmenta-
tion. Bars: D-G = 100 μ m; H-S = 20 μ m. * p < 0.05, ** p < 0.01, *** p < 0.001, one-way ANOVA.Journal of Neuroinflammation 2009, 6:38 http://www.jneuroinflammation.com/content/6/1/38
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Although our study deals almost exclusively with children
- and adult epilepsy may differ fundamentally in its patho-
physiology including the contribution of inflammation -
our results, together with those from other studies, suggest
that activation of microglia is an important associated fea-
ture of chronic intractable epilepsy.
In our study, astrocytic activation was particularly striking
in the cortex; the infiltrative astrogliosis was associated
with up-regulation of selective cytokines. Although astro-
glial proliferation is a well-known accompaniment of a
sclerotic hippocampus in adult patients with temporal
lobe epilepsy [27], a causative role of activated astrocytes
in ictogenesis, seizure maintenance and epileptogenesis
has only recently been recognized. Direct stimulation of
astrocytes is sufficient to cause a paroxysmal depolariza-
tion shift (PDS) and neuronal synchronization in acute
seizure models [28]. Activated astrocytes display distinct
changes in glial membrane channels and receptors to pro-
mote neuronal hyperexcitability and seizure generation
[29].
A massive inflammatory response induced by seizures and
interactions between microglia, astrocytes and neurons
may be an important component in epileptogenesis.
Complex cross-talks between microglia and astrocyte dur-
ing neuroinflammatory insults can influence glutamate-
dependent responses and immune regulatory role of
astrocytes [30]. All our patients showed diffuse astrocyto-
sis in the epileptogenic cortices, and these proliferative
astrocytes were found in close proximity to activated
microglia and neurons, strategically positioned to allow
such cross-talk.
Reactive microglia and astrocytes provide a rich source of
cytokines after injury or insult [31]. Cytokines, in turn,
can influence the activation of astrocytes and microglia.
Injection of pro-inflammatory cytokines, for example, can
induce astrogliosis in healthy animals [32], while injury-
induced microglial activation is suppressed in TNF recep-
tor-knockout mice [33]. Causative role of cytokines in epi-
leptogenesis remains to be elucidated. Cytokines may
contribute initially perhaps by inciting seizures in the
developing brain after being induced by seizures or tissue
injury, exacerbate tissue injury and promote further sei-
zures. Alternatively, neuroinflammation may be a mere
byproduct of epilepsy, rather than causally related. Pre-
treatment with IL-1 receptor antagonists was recently
shown to significantly reduce blood brain barrier (BBB)
disruption and delay the onset of status epilepticus in the
lithium-pilocarpine seizure models [34], further support-
ing the contribution of cytokines and BBB damage to epi-
lepsy. Furthermore, cytokine gene polymorphisms have
been linked to epilepsy susceptibility. The increased fre-
quency of biallelic polymorphisms in the promoter
region of IL-1β at the -511 position were reported in
patients with temporal lobe epilepsy with hippocampal
sclerosis, and in prolonged febrile convulsion [35]. We
found significantly higher IL-6 and MCP-1 level in our
small number of patients with a family history of epilepsy.
It may be worthwhile to explore further a possible link
between chronic epilepsy and genetic susceptibility to
inflammation.
Investigations in the most extreme case of seizure activity
- status epilepticus - in both human and animals demon-
strate that prolonged seizures can cause neuronal death
[36,37]. Glutamate-mediated excitotoxicity, necrosis and
activation of apoptosis are contributing mechanisms
[38,39]. Thus the finding that frequent discrete seizures in
our patients may have caused both immediate necrotic
and delayed apoptotic cell death was not surprising. An
unexpected finding was the degree and extent of the cell
injury seen in our pediatric cases in contrast to adult
patients with TLE [25]. Necrosis, often TUNEL-positive, is
the main form of seizure-induced cell death and is known
to induce an inflammatory response. Therefore, glial reac-
tion may be a result of cell death as well as a trigger. Inter-
estingly, DNA fragmentation was not correlated with the
magnitude of glial reaction in our study raising the possi-
bility that frequent seizures may be responsible for both
cell death and glial reaction. Seizure-induced cognitive
impairments are influenced by the extent of damage
caused by seizures in animal models [40]. This result is
supported by our finding that majority of our patients
with abundant cell injury have mental retardation. It
appears that intractable epilepsy in childhood due to focal
cortical dysplasia and encephalomalacia as well as Ras-
mussen's encephalitis are marked by ongoing active cell
injury.
While the majority of the cell population showing DNA
fragmentation in the cortex are neurons, we found that
over 25% of DNA fragmentation was due to astroglial
damage. In children having recent seizures, CSF GFAP lev-
els were significantly elevated within 24 hours, and corre-
lated with seizure duration, suggesting that astrocytic
injury may occur primarily during prolonged seizures
[41]. Astrocytes are thought to be more resistant to injury
compared to neurons and oligodendrocytes, which are
both vulnerable to glutamate-mediated death [42]. At 6-
24 hours after status epilepticus, however, TUNEL-posi-
tive astrocytes and neurons are increased and then subse-
quently reduced after 7-14 days due to phagocytosis by
activated microglia/macrophages [43].
In summary, neuroinflammation and ongoing cell injury
were extensive and wide-spread in our patients with
intractable epilepsy. Although it is not possible to infer
causality from descriptive human studies, our data suggestJournal of Neuroinflammation 2009, 6:38 http://www.jneuroinflammation.com/content/6/1/38
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that increased seizure frequency is associated with
increased neuronal and astrocytic injury, and that fre-
quent seizures are also associated with massive glial acti-
vation and inflammatory responses in the epileptogenic
cortex. Microglial activation, astocytic proliferation, and
proinflammatory cytokine production may promote sei-
zures, further exacerbate epilepsy and cause subsequent
degeneration of neurons, astrocytes and oligodendro-
cytes. If so, there may be a potential role for anti-inflam-
matory therapy targeting activated astrocytes and
microglia as a novel therapeutic strategy to prevent or
limit epileptogenesis and cell injury associated with sei-
zures in the vulnerable developing nervous system.
Cytokine analysis by ELISA Figure 5
Cytokine analysis by ELISA. IL-1β (A), IL-8 (B) and MIP-1β (C) are significantly increased in brains of patients with epilepsy 
(p < 0.05) whereas. IL-6 (D), MCP-1 (E) and IP-10 (F) show sporadic and variable increases in our patients with epilepsy. Note 
that some of our patients show highly elevated cytokine release comparable to Rasmussen's encephalitis (black circle). IL-6 (G) 
and MCP-1 (H) are significantly increased in brains from patients with a family history of epilepsy (p < 0.05). Rasmussen's 
encephalitis patient (black circle) is the only one who shows high IL-6 and MCP-1 levels among the patients without family his-
tory of epilepsy.Journal of Neuroinflammation 2009, 6:38 http://www.jneuroinflammation.com/content/6/1/38
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